-
1
-
-
50949120914
-
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition
-
Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr. 2008; 28:115-130.
-
(2008)
Annu Rev Nutr
, vol.28
, pp. 115-130
-
-
Bogan, K.L.1
Brenner, C.2
-
2
-
-
84055223632
-
The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism
-
Garavaglia S, Bruzzone S, Cassani C, Canella L, Allegrone G, Sturla L, Mannino E, Millo E, De Flora A, Rizzi M. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem J. 2012; 441:131-141.
-
(2012)
Biochem J
, vol.441
, pp. 131-141
-
-
Garavaglia, S.1
Bruzzone, S.2
Cassani, C.3
Canella, L.4
Allegrone, G.5
Sturla, L.6
Mannino, E.7
Millo, E.8
De Flora, A.9
Rizzi, M.10
-
3
-
-
0036856578
-
Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis
-
Rongvaux A, Shea R J, Mulks MH, Gigot D, Urbain J, Leo O, Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002; 32:3225-3234.
-
(2002)
Eur J Immunol
, vol.32
, pp. 3225-3234
-
-
Rongvaux, A.1
Shea, R.J.2
Mulks, M.H.3
Gigot, D.4
Urbain, J.5
Leo, O.6
Andris, F.7
-
4
-
-
63849199824
-
The NMN/NaMN adenylyltransferase (NMNAT) protein family
-
Lau C, Niere M, Ziegler M. The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci. 2009; 14:410-431.
-
(2009)
Front Biosci
, vol.14
, pp. 410-431
-
-
Lau, C.1
Niere, M.2
Ziegler, M.3
-
5
-
-
84937524287
-
Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues
-
Ruggieri S, Orsomando G, Sorci L, Raffaelli N. Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues. Biochim Biophys Acta. 2015; 1854:1138-1149.
-
(2015)
Biochim Biophys Acta
, vol.1854
, pp. 1138-1149
-
-
Ruggieri, S.1
Orsomando, G.2
Sorci, L.3
Raffaelli, N.4
-
6
-
-
84881367747
-
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhib-itors
-
Galli U, Travelli C, Massarotti A, Fakhfouri G, Rahimian R, Tron GC, Genazzani AA. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhib-itors. J Med Chem. 2013; 56:6279-6296.
-
(2013)
J Med Chem
, vol.56
, pp. 6279-6296
-
-
Galli, U.1
Travelli, C.2
Massarotti, A.3
Fakhfouri, G.4
Rahimian, R.5
Tron, G.C.6
Genazzani, A.A.7
-
7
-
-
84930081819
-
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
-
Sampath D, Zabka TS, Misner DL, O'Brien T, Dragovich PS. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. Pharmacol Ther. 2015; 151:16-31.
-
(2015)
Pharmacol Ther
, vol.151
, pp. 16-31
-
-
Sampath, D.1
Zabka, T.S.2
Misner, D.L.3
O'Brien, T.4
Dragovich, P.S.5
-
8
-
-
84878580639
-
Nicotinamide phosphoribosyltransferase (NAMPT) inhib-itors as therapeutics: rationales, controversies, clinical experience
-
Montecucco F, Cea M, Bauer I, Soncini D, Caffa I, Lasigliè D, Nahimana A, Uccelli A, Bruzzone S, Nencioni A. Nicotinamide phosphoribosyltransferase (NAMPT) inhib-itors as therapeutics: rationales, controversies, clinical experience. Curr Drug Targets. 2013; 14:637-643.
-
(2013)
Curr Drug Targets
, vol.14
, pp. 637-643
-
-
Montecucco, F.1
Cea, M.2
Bauer, I.3
Soncini, D.4
Caffa, I.5
Lasigliè, D.6
Nahimana, A.7
Uccelli, A.8
Bruzzone, S.9
Nencioni, A.10
-
9
-
-
84876717815
-
Rejuvenating sirtuins: the rise of a new family of cancer drug targets
-
Bruzzone S, Parenti MD, Grozio A, Ballestrero A, Bauer I, Del Rio A, Nencioni A. Rejuvenating sirtuins: the rise of a new family of cancer drug targets. Curr Pharm Des. 2013; 19:614-623.
-
(2013)
Curr Pharm Des
, vol.19
, pp. 614-623
-
-
Bruzzone, S.1
Parenti, M.D.2
Grozio, A.3
Ballestrero, A.4
Bauer, I.5
Del Rio, A.6
Nencioni, A.7
-
10
-
-
84870363221
-
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses
-
Bauer I, Grozio A, Lasigliè D, Basile G, Sturla L, Magnone M, Sociali G, Soncini D, Caffa I, Poggi A, Zoppoli G, Cea M, Feldmann G, et al. The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J Biol Chem. 2012; 287:40924-40937.
-
(2012)
J Biol Chem
, vol.287
, pp. 40924-40937
-
-
Bauer, I.1
Grozio, A.2
Lasigliè, D.3
Basile, G.4
Sturla, L.5
Magnone, M.6
Sociali, G.7
Soncini, D.8
Caffa, I.9
Poggi, A.10
Zoppoli, G.11
Cea, M.12
Feldmann, G.13
-
11
-
-
80053350162
-
CD38 and chronic lymphocytic leukemia: a decade later
-
Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N. CD38 and chronic lymphocytic leukemia: a decade later. Blood. 2011; 118:3470-3478.
-
(2011)
Blood
, vol.118
, pp. 3470-3478
-
-
Malavasi, F.1
Deaglio, S.2
Damle, R.3
Cutrona, G.4
Ferrarini, M.5
Chiorazzi, N.6
-
12
-
-
0242526050
-
FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribo-syltransferase, represents a novel mechanism for induction of tumor cell apoptosis
-
Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribo-syltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003; 63:7436-7442.
-
(2003)
Cancer Res
, vol.63
, pp. 7436-7442
-
-
Hasmann, M.1
Schemainda, I.2
-
13
-
-
84891510983
-
Nicotinamide Phosphoribosyltransferase in Malignancy: A Review
-
Shackelford RE, Mayhall K, Maxwell NM, Kandil E, Coppola D. Nicotinamide Phosphoribosyltransferase in Malignancy: A Review. Genes Cancer. 2013; 4:447-456. doi:10.1177/1947601913507576.
-
(2013)
Genes Cancer
, vol.4
, pp. 447-456
-
-
Shackelford, R.E.1
Mayhall, K.2
Maxwell, N.M.3
Kandil, E.4
Coppola, D.5
-
14
-
-
70949092805
-
Catastrophic NAD depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE
-
Bruzzone S, Fruscione F, Morando S, Ferrando T, Poggi A, Garuti A, D'Urso A, Selmo M, Benvenuto F, Cea M, Zoppoli G, Moran E, Soncini D, et al. Catastrophic NAD depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PLoS One. 2009; 4:e7897.
-
(2009)
PLoS One
, vol.4
-
-
Bruzzone, S.1
Fruscione, F.2
Morando, S.3
Ferrando, T.4
Poggi, A.5
Garuti, A.6
D'Urso, A.7
Selmo, M.8
Benvenuto, F.9
Cea, M.10
Zoppoli, G.11
Moran, E.12
Soncini, D.13
-
15
-
-
84873291018
-
Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD biosynthesis, in human cancer cells: metabolic basis and potential clinical implications
-
Tan B, Young DA, Lu ZH, Wang T, Meier TI, Shepard RL, Roth K, Zhai Y, Huss K, Kuo MS, Gillig J, Parthasarathy S, Burkholder TP, et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J Biol Chem. 2013; 288:3500-3511.
-
(2013)
J Biol Chem
, vol.288
, pp. 3500-3511
-
-
Tan, B.1
Young, D.A.2
Lu, Z.H.3
Wang, T.4
Meier, T.I.5
Shepard, R.L.6
Roth, K.7
Zhai, Y.8
Huss, K.9
Kuo, M.S.10
Gillig, J.11
Parthasarathy, S.12
Burkholder, T.P.13
-
16
-
-
38149105811
-
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
-
Holen K, Saltz LB, Hollywood E, Burk K, Hanauske AR. The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest New Drugs. 2008; 26:45-51.
-
(2008)
Invest New Drugs
, vol.26
, pp. 45-51
-
-
Holen, K.1
Saltz, L.B.2
Hollywood, E.3
Burk, K.4
Hanauske, A.R.5
-
17
-
-
33748707427
-
Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents
-
Pogrebniak A, Schemainda I, Azzam K, Pelka-Fleischer R, Nussler V, Hasmann M. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents. Eur J Med Res. 2006; 11: 313-321.
-
(2006)
Eur J Med Res
, vol.11
, pp. 313-321
-
-
Pogrebniak, A.1
Schemainda, I.2
Azzam, K.3
Pelka-Fleischer, R.4
Nussler, V.5
Hasmann, M.6
-
18
-
-
84921043647
-
NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone
-
Moore Z, Chakrabarti G, Luo X, Ali A, Hu Z, Fattah FJ, Vemireddy R, DeBerardinis RJ, Brekken RA, Boothman DA. NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone. Cell Death Dis. 2015; 6:e1599.
-
(2015)
Cell Death Dis
, vol.6
-
-
Moore, Z.1
Chakrabarti, G.2
Luo, X.3
Ali, A.4
Hu, Z.5
Fattah, F.J.6
Vemireddy, R.7
DeBerardinis, R.J.8
Brekken, R.A.9
Boothman, D.A.10
-
19
-
-
84867085097
-
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
-
Bajrami I, Kigozi A, Van Weverwijk A, Brough R, Lord CJ, Ashworth A. Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells. EMBO Mol Med. 2012; 4:1087-1096.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 1087-1096
-
-
Bajrami, I.1
Kigozi, A.2
Van Weverwijk, A.3
Brough, R.4
Lord, C.J.5
Ashworth, A.6
-
20
-
-
78649374522
-
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells
-
Zoppoli G, Cea M, Soncini D, Fruscione F, Rudner J, Moran E, Caffa I, Bedognetti D, Motta G, Ghio R, Ferrando F, Ballestrero A, Parodi S, et al. Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. Exp Hematol. 2010; 38:979-988.
-
(2010)
Exp Hematol
, vol.38
, pp. 979-988
-
-
Zoppoli, G.1
Cea, M.2
Soncini, D.3
Fruscione, F.4
Rudner, J.5
Moran, E.6
Caffa, I.7
Bedognetti, D.8
Motta, G.9
Ghio, R.10
Ferrando, F.11
Ballestrero, A.12
Parodi, S.13
-
21
-
-
79960821550
-
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells
-
Cea M, Soncini D, Fruscione F, Raffaghello L, Garuti A, Emionite L, Moran E, Magnone M, Zoppoli G, Reverberi D, Caffa I, Salis A, Cagnetta A, et al. Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. PloS One. 2011; 6:e22739.
-
(2011)
PloS One
, vol.6
-
-
Cea, M.1
Soncini, D.2
Fruscione, F.3
Raffaghello, L.4
Garuti, A.5
Emionite, L.6
Moran, E.7
Magnone, M.8
Zoppoli, G.9
Reverberi, D.10
Caffa, I.11
Salis, A.12
Cagnetta, A.13
-
22
-
-
84942885599
-
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
-
Cagnetta A, Caffa I, Acharya C, Soncini D, Acharya P, Adamia S, Pierri I, Bergamaschi M, Garuti A, Fraternali G, Mastracci L, Provenzani A, Zucal C, et al. APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells. Clin Cancer Res. 2015; 21:3934-45.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 3934-3945
-
-
Cagnetta, A.1
Caffa, I.2
Acharya, C.3
Soncini, D.4
Acharya, P.5
Adamia, S.6
Pierri, I.7
Bergamaschi, M.8
Garuti, A.9
Fraternali, G.10
Mastracci, L.11
Provenzani, A.12
Zucal, C.13
-
23
-
-
84906070287
-
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody
-
Nahimana A, Aubry D, Breton CS, Majjigapu SR, Sordat B, Vogel P, Duchosal MA. The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody. Leuk Lymphoma. 2014; 55: 2141-2150.
-
(2014)
Leuk Lymphoma
, vol.55
, pp. 2141-2150
-
-
Nahimana, A.1
Aubry, D.2
Breton, C.S.3
Majjigapu, S.R.4
Sordat, B.5
Vogel, P.6
Duchosal, M.A.7
-
24
-
-
84896395555
-
NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study
-
Zerp SF, Vens C, Floot B, Verheij M, van Triest B. NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study. Radiother Oncol. 2014; 110:348-354.
-
(2014)
Radiother Oncol
, vol.110
, pp. 348-354
-
-
Zerp, S.F.1
Vens, C.2
Floot, B.3
Verheij, M.4
van Triest, B.5
-
25
-
-
84883738070
-
CD73 protein as a source of extracellular precursors for sustained NAD biosynthesis in FK866-treated tumor cells
-
Grozio A, Sociali G, Sturla L, Caffa I, Soncini D, Salis A, Raffaelli N, De Flora A, Nencioni A, Bruzzone S. CD73 protein as a source of extracellular precursors for sustained NAD biosynthesis in FK866-treated tumor cells. J Biol Chem. 2013; 288:25938-25949.
-
(2013)
J Biol Chem
, vol.288
, pp. 25938-25949
-
-
Grozio, A.1
Sociali, G.2
Sturla, L.3
Caffa, I.4
Soncini, D.5
Salis, A.6
Raffaelli, N.7
De Flora, A.8
Nencioni, A.9
Bruzzone, S.10
-
26
-
-
14944349319
-
Autocrine and paracrine calcium signaling by the CD38/NAD/cyclic ADP-ribose system
-
De Flora A, Zocchi E, Guida L, Franco L, Bruzzone S. Autocrine and paracrine calcium signaling by the CD38/NAD/cyclic ADP-ribose system. Ann NY Acad Sci. 2004; 1028:176-191.
-
(2004)
Ann NY Acad Sci
, vol.1028
, pp. 176-191
-
-
De Flora, A.1
Zocchi, E.2
Guida, L.3
Franco, L.4
Bruzzone, S.5
-
27
-
-
80053920774
-
Nicotinamide mononucleotide, a key NAD intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice
-
Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab. 2011; 14:528-536.
-
(2011)
Cell Metab
, vol.14
, pp. 528-536
-
-
Yoshino, J.1
Mills, K.F.2
Yoon, M.J.3
Imai, S.4
-
28
-
-
0035235938
-
Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD fluxes in intact cells
-
Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD fluxes in intact cells. FASEB J. 2001; 15:10-12.
-
(2001)
FASEB J
, vol.15
, pp. 10-12
-
-
Bruzzone, S.1
Guida, L.2
Zocchi, E.3
Franco, L.4
De Flora, A.5
-
29
-
-
0035930624
-
A self-restricted CD38-connexin 43 cross-talk affects NAD and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts
-
Bruzzone S, Franco L, Guida L, Zocchi E, Contini P, Bisso A, Usai C, De Flora A. A self-restricted CD38-connexin 43 cross-talk affects NAD and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J Biol Chem. 2001; 276:48300-48308.
-
(2001)
J Biol Chem
, vol.276
, pp. 48300-48308
-
-
Bruzzone, S.1
Franco, L.2
Guida, L.3
Zocchi, E.4
Contini, P.5
Bisso, A.6
Usai, C.7
De Flora, A.8
-
31
-
-
84905455228
-
Targeting cancer-derived adenosine: new therapeutic approaches
-
Young A, Mittal D, Stagg J, Smyth MJ. Targeting cancer-derived adenosine: new therapeutic approaches. Cancer Discov. 2014; 4:879-888.
-
(2014)
Cancer Discov
, vol.4
, pp. 879-888
-
-
Young, A.1
Mittal, D.2
Stagg, J.3
Smyth, M.J.4
-
32
-
-
79957553355
-
Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread
-
Salmi M, Jalkanen S. Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. FEBS Lett. 2011; 585:1543-1550.
-
(2011)
FEBS Lett
, vol.585
, pp. 1543-1550
-
-
Salmi, M.1
Jalkanen, S.2
-
33
-
-
75949112218
-
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
-
Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smith MJ. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA. 2010; 107:1547-1552.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 1547-1552
-
-
Stagg, J.1
Divisekera, U.2
McLaughlin, N.3
Sharkey, J.4
Pommey, S.5
Denoyer, D.6
Dwyer, K.M.7
Smith, M.J.8
-
34
-
-
77955750932
-
CD73. A novel target for cancer immunotherapy
-
Zhang B. CD73. A novel target for cancer immunotherapy. Cancer Res. 2010; 70:6407-6411.
-
(2010)
Cancer Res
, vol.70
, pp. 6407-6411
-
-
Zhang, B.1
-
35
-
-
82955217840
-
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
-
Serra S, Horenstein AL, Vaisitti T, Brusa D, Rossi D, Laurenti L, D'Arena G, Coscia M, Tripodo C, Inghirami G, Robson SC, Gaidano G, Malavasi F, et al. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood. 2011;118:6141-6152.
-
(2011)
Blood
, vol.118
, pp. 6141-6152
-
-
Serra, S.1
Horenstein, A.L.2
Vaisitti, T.3
Brusa, D.4
Rossi, D.5
Laurenti, L.6
D'Arena, G.7
Coscia, M.8
Tripodo, C.9
Inghirami, G.10
Robson, S.C.11
Gaidano, G.12
Malavasi, F.13
-
36
-
-
84865429151
-
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma
-
Forte G, Sorrentino R, Montinaro A, Luciano A, Adcock IM, Maiolino P, Arra C, Cicala C, Pinto A, Morello S. Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma. J Immunol. 2012; 189: 2226-2233.
-
(2012)
J Immunol
, vol.189
, pp. 2226-2233
-
-
Forte, G.1
Sorrentino, R.2
Montinaro, A.3
Luciano, A.4
Adcock, I.M.5
Maiolino, P.6
Arra, C.7
Cicala, C.8
Pinto, A.9
Morello, S.10
-
38
-
-
84915749670
-
CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients
-
Huang R, Wu D, Yuan Y, Li X, Holm R, Trope CG, Nesland JM, Suo Z. CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients. PLoS One. 2014; 9:e112209.
-
(2014)
PLoS One
, vol.9
-
-
Huang, R.1
Wu, D.2
Yuan, Y.3
Li, X.4
Holm, R.5
Trope, C.G.6
Nesland, J.M.7
Suo, Z.8
-
39
-
-
58149394856
-
Application of a coupled enzyme assay to characterize nicotinamide riboside kinases
-
Dölle C, Ziegler M. Application of a coupled enzyme assay to characterize nicotinamide riboside kinases. Anal Biochem. 2009; 385:377-379.
-
(2009)
Anal Biochem
, vol.385
, pp. 377-379
-
-
Dölle, C.1
Ziegler, M.2
-
40
-
-
0023947964
-
Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain
-
Okuno E, White RJ, Schwarcz R. Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain. J Biochem. 1988; 103:1054-1059.
-
(1988)
J Biochem
, vol.103
, pp. 1054-1059
-
-
Okuno, E.1
White, R.J.2
Schwarcz, R.3
-
41
-
-
84878595867
-
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress
-
Sahm F, Oezen I, Opitz CA, Radlwimmer B, von Deimling A, Ahrendt T, Adams S, Bode HB, Guillemin GJ, Wick W, Platten M. The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res. 2013; 73:3225-3234.
-
(2013)
Cancer Res
, vol.73
, pp. 3225-3234
-
-
Sahm, F.1
Oezen, I.2
Opitz, C.A.3
Radlwimmer, B.4
von Deimling, A.5
Ahrendt, T.6
Adams, S.7
Bode, H.B.8
Guillemin, G.J.9
Wick, W.10
Platten, M.11
-
42
-
-
0032558401
-
The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries
-
Sauve AA, Munshi C, Lee HC, Schramm VL. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries. Biochemistry 1998; 37:13239-13249.
-
(1998)
Biochemistry
, vol.37
, pp. 13239-13249
-
-
Sauve, A.A.1
Munshi, C.2
Lee, H.C.3
Schramm, V.L.4
-
43
-
-
0027944850
-
Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity
-
GraeffRM, Walseth TF, Fryxell K, Branton WD, Lee HC. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem. 1994; 269:30260-30267.
-
(1994)
J Biol Chem
, vol.269
, pp. 30260-30267
-
-
Graeff, R.M.1
Walseth, T.F.2
Fryxell, K.3
Branton, W.D.4
Lee, H.C.5
-
44
-
-
79957549799
-
Pathways and subcellular compartmentation of NAD biosynthesis in human cells. From entry of extracellular precursors to mitochondrial NAD generation
-
Nikiforov A, Dölle C, Niere M, Ziegler, M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells. From entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. 2011; 286: 21767-21778.
-
(2011)
J Biol Chem
, vol.286
, pp. 21767-21778
-
-
Nikiforov, A.1
Dölle, C.2
Niere, M.3
Ziegler, M.4
-
45
-
-
84919363649
-
Depletion of the central metabolite NAD leads to oncosis-mediated cell death
-
Del Nagro C, Xiao Y, Rangell L, Reichelt M, O'Brien T. Depletion of the central metabolite NAD leads to oncosis-mediated cell death. J Biol Chem. 2014; 289:35182-351892.
-
(2014)
J Biol Chem
, vol.289
, pp. 35182-351892
-
-
Del Nagro, C.1
Xiao, Y.2
Rangell, L.3
Reichelt, M.4
O'Brien, T.5
-
46
-
-
84872437664
-
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction
-
Montecucco F, Bauer I, Braunersreuther V, Bruzzone S, Akhmedov A, Lüscher TF, Speer T, Poggi A, Mannino E, Pelli G, Galan K, Bertolotto M, Lenglet S, et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. Antioxid Redox Signal. 2013; 18:630-641.
-
(2013)
Antioxid Redox Signal
, vol.18
, pp. 630-641
-
-
Montecucco, F.1
Bauer, I.2
Braunersreuther, V.3
Bruzzone, S.4
Akhmedov, A.5
Lüscher, T.F.6
Speer, T.7
Poggi, A.8
Mannino, E.9
Pelli, G.10
Galan, K.11
Bertolotto, M.12
Lenglet, S.13
-
47
-
-
84891590151
-
Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models
-
O'Brien T, Oeh J, Xiao Y, Liang X, Vanderbilt A, Qin A, Yang L, Lee LB, Ly J, Cosino E, LaCap JA, Ogasawara A, Williams S, et al. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models. Neoplasia. 2013; 15:1314-1329.
-
(2013)
Neoplasia
, vol.15
, pp. 1314-1329
-
-
O'Brien, T.1
Oeh, J.2
Xiao, Y.3
Liang, X.4
Vanderbilt, A.5
Qin, A.6
Yang, L.7
Lee, L.B.8
Ly, J.9
Cosino, E.10
LaCap, J.A.11
Ogasawara, A.12
Williams, S.13
-
48
-
-
84889046051
-
NAD biosynthesis in humans-enzymes, metabolites and therapeutic aspects
-
Dölle C, Skoge RH, Vanlinden MR, Ziegler M. NAD biosynthesis in humans-enzymes, metabolites and therapeutic aspects. Curr Top Med Chem. 2013; 13: 2907-2917.
-
(2013)
Curr Top Med Chem
, vol.13
, pp. 2907-2917
-
-
Dölle, C.1
Skoge, R.H.2
Vanlinden, M.R.3
Ziegler, M.4
-
49
-
-
84910142746
-
Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells
-
Zamporlini F, Ruggieri S, Mazzola F, Amici A, Orsomando G, Raffaelli N. Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells. FEBS J. 2014; 281:5104-5119.
-
(2014)
FEBS J
, vol.281
, pp. 5104-5119
-
-
Zamporlini, F.1
Ruggieri, S.2
Mazzola, F.3
Amici, A.4
Orsomando, G.5
Raffaelli, N.6
-
50
-
-
84862022077
-
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
-
Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012; 15:838-847.
-
(2012)
Cell Metab
, vol.15
, pp. 838-847
-
-
Cantó, C.1
Houtkooper, R.H.2
Pirinen, E.3
Youn, D.Y.4
Oosterveer, M.H.5
Cen, Y.6
Fernandez-Marcos, P.J.7
Yamamoto, H.8
Andreux, P.A.9
Cettour-Rose, P.10
Gademann, K.11
Rinsch, C.12
Schoonjans, K.13
-
51
-
-
84900529511
-
Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury
-
Zhao Y, Liu XZ, Tian WW, Guan YF, Wang P, Miao CY. Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury. CNS Neurosci Ther. 2014; 20:539-547.
-
(2014)
CNS Neurosci Ther
, vol.20
, pp. 539-547
-
-
Zhao, Y.1
Liu, X.Z.2
Tian, W.W.3
Guan, Y.F.4
Wang, P.5
Miao, C.Y.6
-
52
-
-
31544466507
-
Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes
-
Bruzzone S, Moreschi I, Guida L, Usai C, Zocchi E, De Flora A. Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes. Biochem J. 2006; 393:697-704.
-
(2006)
Biochem J
, vol.393
, pp. 697-704
-
-
Bruzzone, S.1
Moreschi, I.2
Guida, L.3
Usai, C.4
Zocchi, E.5
De Flora, A.6
-
53
-
-
84900530332
-
Nucleotide signalling during inflammation
-
Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature. 2014; 509:310-317.
-
(2014)
Nature
, vol.509
, pp. 310-317
-
-
Idzko, M.1
Ferrari, D.2
Eltzschig, H.K.3
-
54
-
-
84871852287
-
[18F] FLT and [18F] FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts
-
Jensen MM1, Erichsen KD, Johnbeck CB, Björkling F, Madsen J, Bzorek M, Jensen PB, Højgaard L, Sehested M, Kjær A. [18F] FLT and [18F] FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts. PLoS One. 2013; 8:e53410.
-
(2013)
PLoS One
, vol.8
-
-
Jensen, M.M.1
Erichsen, K.D.2
Johnbeck, C.B.3
Björkling, F.4
Madsen, J.5
Bzorek, M.6
Jensen, P.B.7
Højgaard, L.8
Sehested, M.9
Kjær, A.10
-
56
-
-
84939182460
-
A, β-Methylene-ADP derivatives and analogs: development of potent and selective ecto-5'-nucleotidase (CD73) inhibitors
-
Bhattarai S, Freundlieb M, Pippel J, Meyer A, Abdelrahman A, Fiene A, Lee S, Zimmermann H, Yegutkia G, Sträter N, El-Tayeb A, Müller CE. a, β-Methylene-ADP derivatives and analogs: development of potent and selective ecto-5'-nucleotidase (CD73) inhibitors. J Med Chem. 2015; 58:6248-6263.
-
(2015)
J Med Chem
, vol.58
, pp. 6248-6263
-
-
Bhattarai, S.1
Freundlieb, M.2
Pippel, J.3
Meyer, A.4
Abdelrahman, A.5
Fiene, A.6
Lee, S.7
Zimmermann, H.8
Yegutkia, G.9
Sträter, N.10
El-Tayeb, A.11
Müller, C.E.12
-
57
-
-
38649133357
-
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells
-
Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, Yin L, Shao Z, Ou Z, Zhou P. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol. 2008; 134:365-372.
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, pp. 365-372
-
-
Wang, L.1
Zhou, X.2
Zhou, T.3
Ma, D.4
Chen, S.5
Zhi, X.6
Yin, L.7
Shao, Z.8
Ou, Z.9
Zhou, P.10
-
58
-
-
84946599682
-
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
-
Turcotte M, Spring K, Pommey S, Chouinard G, Cousineau I, George J, Chen GM, Gendoo DM, Haibe-Kains B, Karn T, Rahimi K, Le Page C, Provencher D, et al. CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancer Res. 2015; 75:4494-4503.
-
(2015)
Cancer Res
, vol.75
, pp. 4494-4503
-
-
Turcotte, M.1
Spring, K.2
Pommey, S.3
Chouinard, G.4
Cousineau, I.5
George, J.6
Chen, G.M.7
Gendoo, D.M.8
Haibe-Kains, B.9
Karn, T.10
Rahimi, K.11
Le Page, C.12
Provencher, D.13
-
59
-
-
84867173653
-
Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration
-
Oh HK, Sin JI, Choi J, Park SH, Lee TS, Choi YS. Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration. J Gynecol Oncol. 2012; 23:274-281.
-
(2012)
J Gynecol Oncol
, vol.23
, pp. 274-281
-
-
Oh, H.K.1
Sin, J.I.2
Choi, J.3
Park, S.H.4
Lee, T.S.5
Choi, Y.S.6
-
60
-
-
84857019139
-
Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma
-
Ho CM, Chang SF, Hsiao CC, Chien TY, Shih DT. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma. J Biomed Sci. 2012;19:23.
-
(2012)
J Biomed Sci
, vol.19
, pp. 23
-
-
Ho, C.M.1
Chang, S.F.2
Hsiao, C.C.3
Chien, T.Y.4
Shih, D.T.5
-
61
-
-
84881188594
-
Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
-
Ljujic B, Milovanovic M, Volarevic V, Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML, Stojkovic M. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep. 2013; 3:2298.
-
(2013)
Sci Rep
, vol.3
, pp. 2298
-
-
Ljujic, B.1
Milovanovic, M.2
Volarevic, V.3
Murray, B.4
Bugarski, D.5
Przyborski, S.6
Arsenijevic, N.7
Lukic, M.L.8
Stojkovic, M.9
-
62
-
-
33750552967
-
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy
-
Pastorino F, Brignole C, Di Paolo D, Nico B, Pezzolo A, Marimpietri D, Pagnan G, Piccardi F, Cilli M, Longhi R, Ribatti D, Corti A, Allen TM, et al. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res. 2006; 66:10073-10082.
-
(2006)
Cancer Res
, vol.66
, pp. 10073-10082
-
-
Pastorino, F.1
Brignole, C.2
Di Paolo, D.3
Nico, B.4
Pezzolo, A.5
Marimpietri, D.6
Pagnan, G.7
Piccardi, F.8
Cilli, M.9
Longhi, R.10
Ribatti, D.11
Corti, A.12
Allen, T.M.13
-
63
-
-
0142169532
-
Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells
-
Bruzzone S, De Flora A, Usai C, GraeffR, Lee HC. Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells. Biochem. J. 2003; 375:395-403.
-
(2003)
Biochem. J
, vol.375
, pp. 395-403
-
-
Bruzzone, S.1
De Flora, A.2
Usai, C.3
Graeff, R.4
Lee, H.C.5
-
64
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
65
-
-
84912572145
-
Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues
-
Mori V, Amici A, Mazzola F, Di Stefano M, Conforti L, Magni G, Ruggieri S, Raffaelli N, Orsomando G. Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues. PLoS One. 2014; 9:e113939.
-
(2014)
PLoS One
, vol.9
-
-
Mori, V.1
Amici, A.2
Mazzola, F.3
Di Stefano, M.4
Conforti, L.5
Magni, G.6
Ruggieri, S.7
Raffaelli, N.8
Orsomando, G.9
|